Background.Cost and clinically significant aderse effects are the major limiting factors of interferon (IFN) use in therapy for chronic hepatitis B irus (HB) infection.

• 背景-治疗费用和显著临床不良反应是应用干扰素治疗慢性乙型肝炎病毒感染的两大主要限制。